Nomura Holdings’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Nomura Holdings’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$764K	–	1732
2020 Q3	$764K	Buy	+15,000	New	+$621K	﹤0.01%	890
2015 Q2	–	Sell	-26,376	Closed	-$401K	–	2141
2015 Q1	$401K	Buy	+26,376	New	+$343K	﹤0.01%	1172
2014 Q2	–	Sell	-12,199	Closed	-$148K	–	3132
2014 Q1	$148K	Buy	+12,199	New	+$207K	﹤0.01%	2422

Nomura Holdings's MNTA Position: Q4 2020 in Review

Nomura Holdings sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 15,000 shares — an estimated $764K sold.

Nomura Holdings first reported a position in MNTA in Q1 2014 and held it in 3 quarters. The position peaked at $764K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Nomura Holdings reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Nomura Holdings sold 15,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $764K.
Nomura Holdings first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
Nomura Holdings's Momenta Pharmaceuticals, Inc. position peaked at $764K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Nomura Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.